Illinois Medicaid Preferred Drug List, Updated April 1, 2014

On April 1, 2014, the Illinois Medicaid Drug and Therapeutics (D&T) Committee added a second long-acting injected (LAI) antipsychotic, Abilify Maintena  to the preferred drug list (PDL); previously, the PDL included only one LAI, Invega Sustenna. Although on the PDL, both LAI medications require prior authorization. This change was effective on April 7, 2014. This document is the full PDL in effect as of April 7, 2014 . . .